3 ms·
> Would it be this GSK Vaccine that just started a clinical study relatively recently? That's the vaccine that GSK is developing as a candidate with the hopes
by chimeracoder 4y ago
> Would it be this GSK Vaccine that just started a clinical study relatively recently?
That's the vaccine that GSK is developing as a candidate with the hopes that it will be superior (and also more lucrative) than Bexsero (the existing vaccine).
It's not inherently a bad thing that this might be an option, especially if it turns out to be effective, but keep in mind that GSK has been working on this for years, and that Bexsero's effectiveness has been widely known for years before that. So having a candidate that may be approved in 2026 or later is... not very reassuring given the threats of treatment resistance..